The current status of immunotherapy for large bowel cancer S. K. Carter Short Review Pages: 199 - 203
Differential effect of asparaginase on lymphocyte subpopulations and alleviation of the immunosuppression by lipopolysaccharide W. C. GordonW. J. MandyM. D. Prager Original Papers Pages: 205 - 209
Active immunotherapy of L1210 leukemia with neuraminidase-treated, drug-resistant L1210 sublines A. V. LeFeverJ. J. KillionG. M. Kollmorgen Original Papers Pages: 211 - 217
Prevention by the MER tubercle bacillus fraction of immunosuppression induced by cancer chemotherapeutic agents Y. StuppR. SaltounD. W. Weiss Original Papers Pages: 219 - 226
Nonspecific immunoprevention of L1210 leukemia by cord factor (6-6′ dimycolate of trehalose) administered in a metabolizable oil C. LeclercA. LamensansE. Lederer Original Papers Pages: 227 - 232
Therapy of spontaneous pulmonary metastases of a murine mammary carcinoma with anaerobic corynebacteria L. MilasK. MasonH. R. Withers Original Papers Pages: 233 - 237
Immunotherapy of EL4 lymphoma with reovirus G. Mark KollmorgenDon C. CoxWilliam A. Sansing Original Papers Pages: 239 - 244
Production of cytotoxic antibody to a benz(a)pyrene-induced sarcoma in mice receiving xenogeneic antitumor immune RNA D. FritzeD. H. KernY. H. Pilch Original Papers Pages: 245 - 250
Immune competence in breast cancer — Relationship of pretreatment immunologic tests to diagnosis and tumor stage P. M. BoltonC. TeasdaleL. E. Hughes Original Papers Pages: 251 - 258
Partial restoration by in vivo thymosin of E-rosettes and delayed-type hypersensitivity reactions in immunodeficient cancer patients L. A. SchaeferJ. U. GuttermanA. L. Goldstein Original Papers Pages: 259 - 264
Regression of tumors by an endotoxin combined with trehalose mycolates of differing structure E. RibiK. TakayamaM. Kelly Original Papers Pages: 265 - 270
Trial of BCG immunotherapy in the treatment of resectable squamous cell carcinoma of the bronchus (stages I and II) P. PouillartG. MathéR. Parrot Short Communication Pages: 271 - 273
The current status of clinical immunotherapy as viewed at the 1976 AACR-ASCO meetings S. K. Carter Current Affairs Pages: 275 - 281